ARCHIVES

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

This article is from The Cancer Letter archive.

Vol. 28 No. 21 | May 24, 2002

Download PDF Visit The Full Archive

Related Articles

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992

Cancer Meetings Listed

November 1, 1996

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010

Reviewers Report Progress In New Drug Prescreen System Development, Commend DTP

December 15, 1989

NCI Cooperative Group Clinical Trials Approved

June 26, 2009

First NCI Director To Resign Due To Presidential Election?

December 15, 2000